These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37186173)

  • 1. Outcomes from a prospectively implemented protocol using apixaban after robot-assisted radical cystectomy.
    Rich JM; Elkun Y; Geduldig J; Lavallee E; Mehrazin R; Attalla K; Wiklund P; Sfakianos JP
    BJU Int; 2023 Oct; 132(4):390-396. PubMed ID: 37186173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolic Events After Robotic Radical Cystectomy: A Comparative Analysis of Extended and Limited Prophylaxis.
    Rich JM; Geduldig J; Elkun Y; Lavallee E; Mehrazin R; Attalla K; Wiklund P; Sfakianos JP
    Urology; 2024 Aug; 190():46-52. PubMed ID: 38663586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis Following Robot-assisted Radical Cystectomy: A Retrospective Feasibility Study at a Single Academic Medical Center.
    Ortiz RM; Golijanin B; O'Rourke TK; Sobel DW; Pillsbury L; T Tucci C; Caffery P; Golijanin D
    Urology; 2021 Oct; 156():154-162. PubMed ID: 34171347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.
    King DA; Pow RE; Dickison DM; Vale PR
    Intern Med J; 2016 Sep; 46(9):1030-7. PubMed ID: 27246450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
    Pariser JJ; Pearce SM; Anderson BB; Packiam VT; Prachand VN; Smith ND; Steinberg GD
    J Urol; 2017 Feb; 197(2):302-307. PubMed ID: 27569434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Predictors of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
    Elsayed AS; Ozair S; Iqbal U; Mostowy M; Jing Z; Gibson S; Durrani M; Hussein AA; Guru KA
    Urology; 2021 Mar; 149():146-153. PubMed ID: 33221416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial.
    Guntupalli SR; Brennecke A; Behbakht K; Tayebnejad A; Breed CA; Babayan LM; Cheng G; Ramzan AA; Wheeler LJ; Corr BR; Lefkowits C; Sheeder J; Matsuo K; Flink D
    JAMA Netw Open; 2020 Jun; 3(6):e207410. PubMed ID: 32589230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.
    Knisely A; Iniesta MD; Batman S; Meyer LA; Soliman PT; Cain KE; Marten C; Chisholm G; Schmeler KM; Taylor JS; Fleming ND
    Gynecol Oncol; 2024 Apr; 183():120-125. PubMed ID: 38368180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy.
    Schomburg J; Krishna S; Soubra A; Cotter K; Fan Y; Brown G; Konety B
    Urol Oncol; 2018 Feb; 36(2):77.e9-77.e13. PubMed ID: 29097086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
    Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI;
    N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Khorana Score for Prediction of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
    Iqbal U; Elsayed AS; Ozair S; Jing Z; James G; Li Q; Hussein AA; Guru KA
    J Endourol; 2021 Jun; 35(6):821-827. PubMed ID: 33218263
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol.
    Chiang HA; Cheng PJ; Speed JM; Steinberg J; Najjar PA; Steele GS; Trinh QD; Eswara JR; Chang SL; Kibel AS; Stopfkuchen-Evans MF; Preston MA
    Eur Urol Focus; 2020 Jan; 6(1):74-80. PubMed ID: 30228076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy.
    Corona LE; Singhal U; Hafez K; Herrel LA; Kaffenberger SD; Montgomery JS; Morgan TM; Weizer AZ; Qin Y; Ambani SN
    Urol Oncol; 2020 Oct; 38(10):797.e1-797.e6. PubMed ID: 32624425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.
    Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA
    Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolism.
    Wysokinski WE; Houghton DE; Casanegra AI; Vlazny DT; Bott-Kitslaar DM; Froehling DA; Hodge DO; Peterson LG; Mcbane RD
    Am J Hematol; 2019 Nov; 94(11):1185-1192. PubMed ID: 31378995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study.
    Westerman ME; Bree KK; Msaouel P; Kukreja JB; Mantaring C; Rukundo I; Gonzalez MG; Gregg JR; Casteel KN; Matin SF
    J Urol; 2022 Oct; 208(4):886-895. PubMed ID: 36082549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
    Weitz JI; Bauersachs R; Becker B; Berkowitz SD; Freitas MCS; Lassen MR; Metzig C; Raskob GE
    JAMA; 2020 Jan; 323(2):130-139. PubMed ID: 31935028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
    Agnelli G; Buller HR; Cohen A; Gallus AS; Lee TC; Pak R; Raskob GE; Weitz JI; Yamabe T
    J Thromb Haemost; 2015 Dec; 13(12):2187-91. PubMed ID: 26407753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
    Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
    Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study.
    Cohoon KP; De Sanctis Y; Haskell L; McBane RD; Spiro TE
    J Thromb Haemost; 2018 Jul; 16(7):1278-1287. PubMed ID: 29753308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.